Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Real Savings: Medicare-Negotiated Discounts On Cancer Drugs Range From 40%-60%
Nov 28 2025
•
By
Cathy Kelly
The CMS price announcement focused on list price discounts, which are not as significant as they look for drugs with big rebates.
(Shutterstock)
More from Medicare
More from Government Payers